Bladder cancer
NEW --- Initial treatment of MIBC
Obiettivo della formazione: Identify appropriate treatment strategies for the initial management of N0 and N+ M0 muscle-invasive bladder cancer (MIBC).
Specializzazione: Urology, Medical oncology, Clinical oncology, Radiation oncology
Pubblico target: Specialists (CME: basic, intermediate), Residents (senior)
Aggiornamento più recente: January 2026
Premessa:
Regulatory approval status of drugs limited to the M0 MIBC setting (status 14 January 2026)
PD-(L)1: programmed death-(ligand) 1
All patients in this course have urothelial carcinoma (UCa) in absence of (extensive) variant histology.